AzTrials
AzTrials

PneumoperitoneumNCT01340989

CO2 Absorption During Laparoscopy

A study testing alteration of the insufflation gas, full conditioning and standard pneumoperitoneum in people with Pneumoperitoneum, run by University Hospital, Gasthuisberg at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

CO2 absorption from the pneumoperitoneum increases over time during laparoscopic procedures. Adding 4% of oxygen to the carbon dioxide was shown in rabbits to decrease CO2 resorbtion through prevention of mesothelial hypoxia. We want to prove this concept in human and expand it to the use of full conditioning. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Pneumoperitoneum
What is being tested?
alteration of the insufflation gas, full conditioning and standard pneumoperitoneum
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteBelgium
Study dates
Aug 2006to Sep 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Women/men planned to undergo a laparoscopic intervention for at least 1 hour and having signed the informed consent

Who cannot join

  • Pregnancy
  • Immunodeficiency
  • Refuse or unable to sign informed consent
  • Chronic disease (i.e. COPD, Crohn, cardiac…)

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • UZ Leuven, campus Gasthuisberg

    Leuven, 3000

Other trials in Belgium

About this study

Official title: Evaluation of Adding 4% of Oxygen and 10% of Nitrous Oxide to the CO2 Pneumoperitoneum Upon CO2 Resorption.

CO2 absorption from the pneumoperitoneum increases over time during laparoscopic procedures. Adding 4% of oxygen to the carbon dioxide was shown in rabbits to decrease CO2 resorbtion through prevention of mesothelial hypoxia. We want to prove this concept in human and expand it to the use of full conditioning.

Read the detailed description

In order to confirm the animal data in the human, a first RCT was performed in which 20 women undergoing a laparoscopy for at least 60 minutes were randomised to a pneumoperitoneum with either 100% carbon dioxide or 96% carbon dioxide plus 4% of oxygen. Insufflation pressure and Trendelenburg were standardised at 15 mm Hg and 30° respectively. In a second trial women were randomized to either 100% carbon dioxide or 86% carbon dioxide plus 4% of oxygen + 10% nitrous oxide + humidification and set temperature of 32°C of the peritoneal cavity.

Being tested
alteration of the insufflation gas, full conditioning, standard pneumoperitoneum
Keywords
women undergoing laparoscopic surgery for: hysterectomy, colpopexy, endometriosis, adhesions or myomas
Medical subject headings
Pneumoperitoneum, Endometriosis, Tissue Adhesions, Myoma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • alteration of the insufflation gasProcedure or surgery

    addition of 4% oxygen

  • full conditioningProcedure or surgery

    addition of 4% oxygen + 10% nitrous oxide to the peritoneum

    • humidification
    • set temperature of 32°C
  • standard pneumoperitoneumProcedure or surgery

    no intervention besides the use of CO2

Study groups in NCT01340989
Study groupRoleWhat they receive
4% oxygenExperimentaladdition of 4% oxygen to the CO2 pneumoperitoneum
Receives: Procedure: alteration of the insufflation gas
full conditioningExperimentalfull conditioning of the peritoneal cavity by the laparoscopic gas: 4% oxygen, 10% nitrous oxide, humidification and set temperature of 32°C
Receives: Procedure: full conditioning
CO2 pneumoperitoneumActive comparatorstandard laparoscopy with CO2 pneumoperitoneum
Receives: Procedure: standard pneumoperitoneum

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. CO2 absorption

    Measurement of end tidal CO2 during laparoscopic surgery; a decrease would improve safety (less hypercarbia)

    Measured: measurements for 60 to 240 minutes on average during surgery

Secondary outcomes (1)
  1. hemodynamic alterations

    control of other hemodynamic alterions during laparoscopic surgery.

    Measured: measurements for 60 to 240 minutes on average during surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2011 (estimated)
  2. Study startAug 2006
  3. Primary completionSep 2011
  4. Study completionSep 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01340989
Sponsor's protocol ID
s52645
Status last verified
Oct 2011
First submitted
21 Apr 2011
Last updated
26 Oct 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing alteration of the insufflation gas, full conditioning and standard pneumoperitoneum in people with Pneumoperitoneum, run by University Hospital, Gasthuisberg at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Oct 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

CO2 absorption (time frame: measurements for 60 to 240 minutes on average during surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2011.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in